/C O R R E C T I O N -- Langar Technology, Inc./

Rhea-AI Summary

Langar Technology (NYSE:LGHT) announced that Langar Investment Management will transfer the primary listing of the Langar Global HealthTech ETF (LGHT) from NYSE Arca to the Cboe BZX Exchange on or about July 27, 2026.

Current shareholders need not take action; trading, investment objective, strategies, and management team are expected to remain unchanged. A prior version contained an incorrect date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

News Market Reaction – LGHT

-3.34%

-3.34% News Effect

On the day this news was published, LGHT declined 3.34%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

In the news release, LANGAR INVESTMENT MANAGEMENT ANNOUNCES TRANSFER OF THE LANGAR GLOBAL HEALTHTECH ETF TO THE CBOE BZX EXCHANGE, issued 07-Jul-2026 by Langar Technology, Inc. over PR Newswire, we are advised by the company that changes have been made. The complete, corrected release follows, with additional details at the end:

LANGAR INVESTMENT MANAGEMENT ANNOUNCES TRANSFER OF THE LANGAR GLOBAL HEALTHTECH ETF TO THE CBOE BZX EXCHANGE

LOS ANGELES, July 7, 2026 /PRNewswire/ -- Langar Investment Management LLC, the adviser to the Langar Global HealthTech ETF (NYSE Arca: LGHT), today announced the transfer of the primary listing of LGHT from NYSE Arca to the Cboe BZX Exchange on or about July 27, 2026.

Current shareholders of LGHT are not required to take any action, nor is the transfer expected to have any effect on the trading of the Fund's shares. The Fund's investment objective, strategies, and investment management team will remain unchanged.

For more information on the Langar Global HealthTech ETF, please visit langarfunds.com.

About Langar Investment Management

Langar Investment Management is the investment management subsidiary of Langar Technology, Inc. and the adviser to the Langar Global HealthTech ETF (LGHT) — the first ever pure-play healthtech ETF. LGHT seeks long-term growth of capital and offers investors targeted exposure to companies at the intersection of healthcare and technology, including digital health, medical devices, health data infrastructure, and AI-driven diagnostics. For more information, visit langarfunds.com.

Important Disclosures

Nothing contained in this material should be construed as an offer to sell nor a solicitation of an offer to buy shares of the Langar Global HealthTech ETF. This material must be preceded or accompanied by a current prospectus. Investors should read the prospectus carefully before investing.

Investing involves risk, including possible loss of principal. The Fund's shares are bought and sold at market price, not at net asset value ("NAV") per share. The shares may trade at a premium or discount to NAV. Brokerage commissions will reduce returns.

The Langar Global HealthTech ETF is distributed by Paralel Distributors LLC. Paralel Distributors LLC is not affiliated with Langar Investment Management or Langar Technology, Inc.

LAN10.

Correction: An earlier version of this release had the incorrect date in paragraph 1.

View original content:https://www.prnewswire.com/news-releases/langar-investment-management-announces-transfer-of-the-langar-global-healthtech-etf-to-the-cboe-bzx-exchange-302819919.html

SOURCE Langar Technology, Inc.

FAQ

What change was announced for the Langar Global HealthTech ETF (LGHT) on July 7, 2026?

Langar Investment Management will transfer the primary listing of LGHT from NYSE Arca to the Cboe BZX Exchange. According to Langar Investment Management, the move is scheduled for on or about July 27, 2026, with no expected change to fund strategy.

When will the Langar Global HealthTech ETF (LGHT) move to the Cboe BZX Exchange?

The LGHT ETF listing transfer to the Cboe BZX Exchange is planned for on or about July 27, 2026. According to Langar Investment Management, this date marks the move from NYSE Arca while maintaining the existing investment objective and strategies.

Do LGHT shareholders need to take any action for the Cboe BZX listing transfer?

Current LGHT shareholders are not required to take any action for the exchange transfer. According to Langar Investment Management, the move from NYSE Arca to Cboe BZX is not expected to affect how fund shares trade in the market.

Will the Langar Global HealthTech ETF (LGHT) change its objective or management after the Cboe transfer?

The fund’s investment objective, strategies, and management team will remain unchanged after the transfer. According to Langar Investment Management, only the primary listing venue is changing, while the healthtech-focused approach and adviser oversight continue as before.

What does the Langar Global HealthTech ETF (LGHT) invest in after the exchange transfer?

LGHT will continue seeking long-term capital growth by targeting companies at the intersection of healthcare and technology. According to Langar Investment Management, the ETF focuses on areas such as digital health, medical devices, health data infrastructure, and AI-driven diagnostics.

How are LGHT shares of the Langar Global HealthTech ETF priced and traded?

LGHT shares are bought and sold on an exchange at market price, not net asset value. According to Langar Investment Management, shares may trade at a premium or discount to NAV, and brokerage commissions can reduce investor returns when trading the ETF.